APP and Cognitive impairment: APP/PS1 transgenic mouse model has been well characterized for cognitive impairment (Lalonde et al., 2005; Volianskis et al., 2010), with the reduction of transient long-term potentiation by 3 months of age (Volianskis et al., 2010).